Table 3.
Demographic and clinical characteristic.
| Viral | Bacterial | Total | P-value | |
|---|---|---|---|---|
| Number of participants | 419 | 42 | 461 | |
| Demographics | ||||
| Age (months) | 15.9 (6.5–30.5) | 7.1 (4.0–26.7) | 15.6 (6.0–29.2) | 0.008 |
| Length of stay (days) | 3.0 (2.0–4.0) | 3.0 (3.0–4.0) | 3.0 (2.0–4.0) | 0.128 |
| Duration of fever (days) | 2.0 (1.0–4.0) | 1.0 (1.0–3.0) | 2.0 (1.0–3.0) | 0.102 |
| ANC | 4558 (2835–7828) | 8638 (4950–11700) | 4717 (2904–8076) | <0.001 |
| Absolute band count | 222.0 (0.0–590.0) | 248.5 (0.0–868.0) | 225.0 (0.0–648.0) | 0.275 |
| Initial temperature (°C) | 100.6 ± 2.1 | 100.6 ± 2.4 | 100.6 ± 2.1 | 0.974 |
| WBC absolute (weeks) | 11.7 ± 5.6 | 16.8 ± 7.5 | 12.1 ± 6.0 | <0.001 |
| Band proportion | 3.7 ± 4.5 | 3.8 ± 4.8 | 3.7 ± 4.5 | 0.885 |
| Neutrophil absolute | 5.5 ± 4.3 | 7.4 ± 4.1 | 5.7 ± 4.3 | 0.009 |
| Neutrophil proportion | 45.3 ± 19.8 | 48.5 ± 18.4 | 45.6 ± 19.7 | 0.319 |
| Lymphocyte absolute | 4.7 ± 4.5 | 5.7 ± 4.1 | 4.8 ± 4.5 | 0.145 |
| Lymphocyte proportion | 40.3 ± 18.8 | 36.9 ± 16.2 | 40.0 ± 18.5 | 0.251 |
| Monocyte absolute | 1.0 ± 0.8 | 1.2 ± 1.0 | 1.1 ± 0.8 | 0.491 |
| Monocyte proportion | 9.1 ± 4.7 | 6.8 ± 5.3 | 8.9 ± 4.8 | 0.004 |
| A/T ratio | 0.1 ± 0.1 | 0.1 ± 0.1 | 0.1 ± 0.1 | 0.861 |
| Female (N, %) | 211 (50.4%) | 25 (59.5%) | 236 (51.2%) | 0.331 |
| Antibiotics given (N, %) | 119 (28.4%) | 39 (92.9%) | 158 (34.3%) | <0.001 |
| Admission to hospital (N, %) | 192 (45.8%) | 26 (61.9%) | 218 (47.3%) | 0.052 |
| Toxic appearance (N, %) | 4 (1.0%) | 0 (0.0%) | 4 (0.9%) | >0.999 |
| Readmission (N, %) | 9 (2.1%) | 0 (0.0%) | 9 (2.0%) | >0.999 |